Search results
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 2 hours agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
Roche Breast Cancer Medicine to Get Expedited FDA Review
Bloomberg· 10 hours agoRoche Holding AG said an experimental breast-cancer treatment will get an expedited review from US...
University Circle PD implements dechokers to save lives
19 Action News Cleveland· 53 minutes agoOfficer Joe Fazio encouraged the department to buy the device. Officer Fazio says a dechoker saved...
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 5 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
FDA OK’s Elon Musk’s Neuralink to implant brain chip into second patient: report
NY Post via Yahoo News· 1 day agoNews of the FDA’s approval was first reported by The Wall Street Journal on Monday. Neuralink has...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 8 hours agoS. Food and Drug Administration (US FDA) has approved the Company's first-to-file application for Yesafili™ (aflibercept-jbvf), an interchangeable ...
Women’s health is so much more than abortion
The Washington Times· 2 hours agoThe Biden White House issued a proclamation that declared National Women’s Health Week the week of May 12-18. Celebrating motherhood and women’s health ...
ENDRA meets with FDA on liver device clinical trial design By Investing.com
Investing.com· 1 day agoS. Food and Drug Administration (FDA) regarding its TAEUS liver device. The meeting, which took...
FDA Approves Pivya, a New Treatment for UTIs in Women
Health via Yahoo News· 1 day ago“The FDA is committed to fostering new antibiotic availability when they prove to be safe and...
Arnold & Porter Hires Former FDA Counsel Eva Temkin as Partner
Bloomberg Law· 6 hours agoEva Temkin has joined Arnold & Porter as a partner with the firm’s life sciences and healthcare regulatory practice in Washington, the firm said Tuesday.
